JGC
REPL icon

J. Goldman & Co’s Replimune Group REPL Stock Holding History

J. Goldman & Co’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,595
Closed -$119K – 846
2025
Q4 		$152K Buy
+15,595
New +$133K ﹤0.01% 523
2025
Q2 		– Sell
-115,861
Closed -$1.01M – 608
2025
Q1 		$1.13M Buy
115,861
+3,178
+3% +$39.3K 0.03% 353
2024
Q4 		$1.36M Buy
112,683
+42,046
+60% +$511K 0.04% 299
2024
Q3 		$774K Sell
70,637
-65,413
-48% -$664K 0.02% 314
2024
Q2 		$1.22M Buy
+136,050
New +$948K 0.03% 288
2023
Q3 		– Sell
-57,120
Closed -$1.12M – 464
2023
Q2 		$1.33M Sell
57,120
-46,603
-45% -$911K 0.05% 235
2023
Q1 		$1.83M Buy
103,723
+17,196
+20% +$409K 0.07% 213
2022
Q4 		$2.35M Buy
+86,527
New +$1.8M 0.12% 166

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

J. Goldman & Co's REPL Position: Q1 2026 in Review

J. Goldman & Co sold out of Replimune Group (REPL) in Q1 2026, closing a stake of 15,595 shares — an estimated $119K sold.

J. Goldman & Co first reported a position in REPL in Q4 2022 and held it in 8 quarters. The position peaked at $2.35M in Q4 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • J. Goldman & Co reported no remaining Replimune Group position as of Q1 2026 after selling out during the quarter.
  • J. Goldman & Co sold 15,595 Replimune Group shares in Q1 2026, an estimated $119K.
  • J. Goldman & Co first reported a position in Replimune Group in Q4 2022 and held it in 8 quarters.
  • J. Goldman & Co's Replimune Group position peaked at $2.35M in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.